Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2015 (2015), Article ID 278591, 8 pages
http://dx.doi.org/10.1155/2015/278591
Research Article

Correlation of Endometrial Glycodelin Expression and Pregnancy Outcome in Cases with Polycystic Ovary Syndrome Treated with Clomiphene Citrate Plus Metformin: A Controlled Study

1Gynecology and Obstetrics Department, Ataturk Training and Research Hospital, Basin Sitesi, Yesilyurt, 35360 İzmir, Turkey
2Gynecology and Obstetrics Department, Izmir University Hospital, 35360 İzmir, Turkey
3Gynecology and Obstetrics Department, Isparta Obstetrics and Pediatrics Hospital, 32000 Isparta, Turkey
4Pathology Department, Ataturk Training and Research Hospital, Basin Sitesi, Yesilyurt, 35360 İzmir, Turkey
5Gynecologic Oncology Department, Suleyman Demirel University Hospital, 32000 Isparta, Turkey
6Gynecology and Obstetrics Department, Aydın Obstetrics and Pediatrics Hospital, 09100 Aydın, Turkey

Received 11 November 2014; Revised 2 February 2015; Accepted 16 February 2015

Academic Editor: Curt W. Burger

Copyright © 2015 Selda Uysal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Jakubowicz, M. Seppälä, S. Jakubowicz et al., “Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 1126–1133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Jakubowicz, P. A. Essah, M. Seppälä et al., “Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 833–839, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Lord, I. H. K. Flight, and R. J. Norman, “Metformin in polycystic ovary syndrome: systematic review and meta-analysis,” British Medical Journal, vol. 327, no. 7421, pp. 951–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Diamanti-Kandarakis, C. D. Christakou, E. Kandaraki, and F. N. Economou, “Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome,” European Journal of Endocrinology, vol. 162, no. 2, pp. 193–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. A. Ehrmann, J. Sturis, M. M. Byrne, T. Karrison, R. L. Rosenfield, and K. S. Polonsky, “Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus,” The Journal of Clinical Investigation, vol. 96, no. 1, pp. 520–527, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Jakubowicz, M. J. Iuorno, S. Jakubowicz, K. A. Roberts, and J. E. Nestler, “Effects of metformin on early pregnancy loss in the polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 524–529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Consensus on infertility treatment related to polycystic ovary syndrome,” Human Reproduction, vol. 23, no. 3, pp. 462–477, 2008. View at Publisher · View at Google Scholar
  8. M. Karaköse, E. Cakal, K. Ertan, and T. Delibaşı, “The metabolic effects of drugs used for the treatment of polycystic ovary syndrome,” Journal of the Turkish German Gynecological Association, vol. 14, no. 3, pp. 168–173, 2013. View at Publisher · View at Google Scholar
  9. A. Stavreus-Evers, E. Mandelin, R. Koistinen, L. Aghajnova, O. Hovatta, and M. Seppälä, “Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B,” Fertility and Sterility, vol. 85, no. 6, pp. 1803–1811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Mylonas, U. Jeschke, C. Kunert-Keil et al., “Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization,” Fertility and Sterility, vol. 86, no. 5, pp. 1488–1497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Alok and A. A. Karande, “The role of glycodelin as an immune-modulating agent at the feto-maternal interface,” Journal of Reproductive Immunology, vol. 83, no. 1-2, pp. 124–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS),” Human Reproduction, vol. 19, no. 1, pp. 41–47, 2004. View at Google Scholar
  13. D. Carter, J. K. Greenson, V. E. Reuter, M. H. Stoler, and S. Mills, Sternberg's Diagnostic Surgical Pathology, 5th edition, 2009.
  14. M. Seppälä, H. Koistinen, R. Koistinen, P. C. N. Chiu, and W. S. B. Yeung, “Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations,” Human Reproduction Update, vol. 13, no. 3, pp. 275–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Seppälä, L. Riittinen, M. Julkunen et al., “Structural studies, localization in tissue and clinical aspects of human endometrial proteins,” Journal of Reproduction and Fertility. Supplement, vol. 36, pp. 127–141, 1988. View at Google Scholar · View at Scopus
  16. D. Mukhopadhyay, S. SundarRaj, A. Alok, and A. A. Karande, “Glycodelin A, not glycodelin S, is apoptotically active: relevance of sialic acid modification,” The Journal of Biological Chemistry, vol. 279, no. 10, pp. 8577–8584, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Jayachandran, C. M. Radcliffe, L. Royle et al., “Oligosaccharides modulate the apoptotic activity of glycodelin,” Glycobiology, vol. 16, no. 11, pp. 1052–1063, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Seppälä, H. Koistinen, R. Koistinen, L. Hautala, P. C. Chiu, and W. S. Yeung, “Glycodelin in reproductive endocrinology and hormone-related cancer,” European Journal of Endocrinology, vol. 160, no. 2, pp. 121–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Watson, D. S. Kiddy, D. Hamilton-Fairley et al., “Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage,” Human Reproduction, vol. 8, no. 6, pp. 829–833, 1993. View at Google Scholar · View at Scopus
  20. T. C. Li, E. Ling, C. Dalton, A. E. Bolton, and I. D. Cooke, “Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women,” British Journal of Obstetrics and Gynaecology, vol. 100, no. 5, pp. 460–464, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. L. C. Kao, S. Tulac, S. Lobo et al., “Global gene profiling in human endometrium during the window of implantation,” Endocrinology, vol. 143, no. 6, pp. 2119–2138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Brown, E. Mandelin, S. Oehninger, J. P. Toner, M. Seppala, and H. W. Jones Jr., “Endometrial glycodelin-A expression in the luteal phase of stimulated ovarian cycles,” Fertility and Sterility, vol. 74, no. 1, pp. 130–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Tulppala, M. Julkunen, A. Tiitinen, U.-H. Stenman, and M. Seppälä, “Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle,” Fertility and Sterility, vol. 63, no. 4, pp. 792–795, 1995. View at Google Scholar · View at Scopus
  24. M. Julkunen, R. Koistinen, J. Sjoberg, E. M. Rutanen, T. Wahlström, and M. Seppälä, “Secretory endometrium synthesizes placental protein 14,” Endocrinology, vol. 118, no. 5, pp. 1782–1786, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Boomsma, M. J. C. Eijkemans, E. G. Hughes, G. H. A. Visser, B. C. J. M. Fauser, and N. S. Macklon, “A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome,” Human Reproduction Update, vol. 12, no. 6, pp. 673–683, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. H. Gray, “Subfertility and risk of spontaneous abortion,” The American Journal of Public Health, vol. 90, no. 9, pp. 1452–1454, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Regan, E. J. Owen, and H. S. Jacobs, “Hypersecretion of luteinising hormone, infertility, and miscarriage,” The Lancet, vol. 336, no. 8724, pp. 1141–1144, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Salim, J. Miel, M. Savvas, C. Lee, and D. Jurkovic, “A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 133, no. 1, pp. 76–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. K. Dalton, S. M. Laird, S. E. Estdale, H. G. Saravelos, and T. C. Li, “Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; Correlation with pregnancy outcome,” Human Reproduction, vol. 13, no. 11, pp. 3197–3202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. L. G. Westergaard, N. Wiberg, C. Yding Andersen et al., “Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles,” Human Reproduction, vol. 13, no. 9, pp. 2612–2619, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Chryssikopoulos, T. Mantzavinos, N. Kanakas, E. Karagouni, E. Dotsika, and P. A. Zourlas, “Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients,” Fertility and Sterility, vol. 66, no. 4, pp. 599–603, 1996. View at Google Scholar · View at Scopus
  32. H.-M. Liu, F.-Q. Xing, and F.-L. Wu, “Glycodelin in IVF-ET cycles: its association with endometrial receptivity and impact on the outcome of pregnancy,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 26, no. 8, pp. 1227–1229, 2006. View at Google Scholar · View at Scopus